C3 Med-Tech Raises Rs 2 Crore To Launch AI-Enabled Eye Screening Devices

C3 Med-Tech, a health tech startup specialising in ophthalmic screening devices in a press statement on Tuesday, announced securing Rs 2 crore in its first equity investment from Industrial Metal Powders. This funding will drive the launch of new telemedicine and AI-enabled portable equipment designed to facilitate efficient and accurate eye checkups and real-time detection of eye diseases, the statement from the company read.

The integration of telemedicine and AI technology in C3 Med-Tech's devices aims to provide immediate and precise diagnoses, enabling timely interventions and significantly enhancing the prevention of visual impairment and blindness. The company's mission focuses on reducing avoidable blindness in India by developing affordable and portable ophthalmic screening devices.

This strategic investment marks a significant milestone for C3 Med-Tech. The company plans to utilise the funds to expand its presence across India and globally through marketing efforts, team building, and further research and development for future products.

Yash Nagarsheth, Founder & CEO of C3 Med-Tech, stated, "This investment will help us accelerate our efforts to expand access, particularly in underserved communities where the need is most acute. Industrial Metal Powders is one of the largest custom surgical implant manufacturers in Southeast Asia. With their guidance and support, we are confident we can make a meaningful impact in the fight against avoidable blindness. We are also strengthening our leadership with an experienced management team and expert ophthalmologists to guide us in developing market-relevant products.”

Prakash Dhoka, Managing Director at Industrial Metal Powders, commented, "We are thrilled to join hands with C3 Med-Tech on their journey to revolutionise eye care. C3 Med-Tech's commitment to leveraging technology for the greater good aligns perfectly with our vision of advancing medical technologies to improve lives."

India faces a significant shortage of ophthalmologists, with only about 30,000 registered specialists serving a population of 1.3 billion.